|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 985.9 DKK | +0.17% |
|
+0.67% | +41.28% |
| 12:30pm | Lilly files additional lawsuits over US sales of counterfeit Mounjaro | RE |
| 12:00pm | Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss waters | RE |
June 14 (Reuters) - The U.S Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a September hearing focusing on U.S. prices for weight loss drugs Ozempic and Wegovy. (Reporting by Puyaan Singh in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| +41.28% | 631B | |
| +52.93% | 803B | |
| -7.08% | 351B | |
| +17.40% | 324B | |
| +10.58% | 303B | |
| +16.72% | 243B | |
| +2.13% | 228B | |
| +10.31% | 217B | |
| +6.24% | 164B | |
| -4.79% | 155B |
NOVO NORDISK A/S 
